首页> 外国专利> Pharmaceutical formulation useful for treating inflammatory and obstructive respiratory diseases comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic

Pharmaceutical formulation useful for treating inflammatory and obstructive respiratory diseases comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic

机译:可用于治疗炎性和阻塞性呼吸道疾病的药物制剂包含至少一种抗胆碱能化合物,至少一种皮质类固醇和至少一种β模拟药

摘要

A pharmaceutical formulation (F1) comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic. A pharmaceutical formulation comprises at least one anticholinergic compound of formula (I) and their enantiomers, racemates, solvates, hydrates and/or acid addition salts; at least one corticosteroid (a1); and at least one betamimetic (a2). X-anion with a single negative charge. [Image] ACTIVITY : Respiratory-Gen.; Antiinflammatory. MECHANISM OF ACTION : None given.
机译:药物制剂(F1)包含至少一种抗胆碱能化合物,至少一种皮质类固醇和至少一种β模拟物。药物制剂包含至少一种式(I)的抗胆碱能化合物及其对映异构体,外消旋体,溶剂化物,水合物和/或酸加成盐;至少一种皮质类固醇(a1);和至少一种Betaimimetic(a2)。 X->带有单个负电荷的阴离子。 [图片]活动:呼吸发生器。消炎(药。作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号